Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors-Reference-Cited by-同舟云学术

Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors

Published:2019-08-29 Issue:11 Volume:352 Page:1900123
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Arch Pharm Chem Life Sci

Author:

Eissa Ibrahim H.¹^ORCID,Metwaly Ahmed M.²,Belal Amany³⁴^ORCID,Mehany Ahmed B.M.⁵,Ayyad Rezk R.¹,El‐Adl Khaled¹⁶^ORCID,Mahdy Hazem A.¹,Taghour Mohammed S.¹,El‐Gamal Kamal M.A.⁷,El‐Sawah Mohamad E.⁷,Elmetwally Souad A.⁸,Elhendawy Mostafa. A.⁹,Radwan Mohamed M.⁹¹⁰,ElSohly Mahmoud A.⁹¹¹

Affiliation:

1. Pharmaceutical Medicinal Chemistry Department, Faculty of Pharmacy (Boys) Al‐Azhar University Cairo Egypt

2. Department of Pharmacognosy, Faculty of Pharmacy (Boys) Al‐Azhar University Cairo Egypt

3. Department of Medicinal Chemistry, Faculty of Pharmacy Beni‐Suef University Beni‐Suef Egypt

4. Department of Pharmaceutical Chemistry, College of Pharmacy Taif University Taif Saudi Arabia

5. Department of Zoology, Faculty of Science Al‐Azhar University Cairo Egypt

6. Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Drug Technology Heliopolis University for Sustainable Development Cairo Egypt

7. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy (Boys) Al‐Azhar University Cairo Egypt

8. Department of Basic Science Higher Technological Institute 10th of Ramadan City Egypt

9. National Center for Natural Products Research University of Mississippi Mississippi

10. Department of Pharmacognosy, Faculty of Pharmacy Alexandria University Alexandria Egypt

11. Department of Pharmaceutics and Drug Delivery University of Mississippi Mississippi Mississippi

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ardp.201900123

Reference57 articles.

1. WHO Cancer Fact Sheet 2018 (accessed October 2018). Retrieved fromhttp://www.who.int/news‐room/fact‐sheets/detail/cancer.

2. Classification of anticancer drugs—a new system based on therapeutic targets

3. DNA and its associated processes as targets for cancer therapy

4. Cellular roles of DNA topoisomerases: a molecular perspective

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beta-1 Receptor (β1) in the Heart Specific Indicate to Stereoselectivity;Archives of Pharmacy and Pharmaceutical Sciences;2024-07-10

2. Recent advances on quinoxalines as target‐oriented chemotherapeutic anticancer agents through apoptosis;Archiv der Pharmazie;2024-05-31

3. Quinoxaline derivatives: Recent discoveries and development strategies towards anticancer agents;European Journal of Medicinal Chemistry;2024-05

4. A quinoxaline-based derivative exhibited potent and selective anticancer activity with apoptosis induction in PC-3 cells through Topo II inhibition;Journal of Biomolecular Structure and Dynamics;2024-03-14

5. A multifaceted approach for the development of novel Hantzsch 1,4-dihydropyridines as anticancer agents: Rational design, parallel synthesis, analysis, cytotoxicity and EGFR/HER2 inhibition studies;Results in Chemistry;2024-01